-The Hindu Business Line Farmers seen bringing more area under the fibre crop this year Ahmedabad / Bengaluru: Sowing of cotton has begun on a strong note in the key growing regions of North India such as Punjab and Haryana, and Southern Karnataka, for the 2017-18 season. Buoyed by the high prevailing prices, farmers are seen bringing in a larger area under the fibre crop and the seed industry expects acreages this year...

-The Financial Express Thanks to normal monsoon rains last year after two consecutive years of ‘deficient’ rainfall, India’s foodgrain production is estimated to touch an all-time high of 273.38 million tonne (MT) in the 2016-17 crop year (July-June), which is 8.7% more than the previous year. The previous record output was 265.04 MT in 2013-14. According to the third advance estimate released on Tuesday by agriculture ministry, the output of rice, wheat,...

-TheWire.in Raising productivity, reforming land policies and solving the remunerative price mess will require massive amounts of public investment and political will. Is the Modi government up to the task? The Niti Aayog recently came out with its ‘Three Year Action Agenda’ – a plan that covers a time period that is politically crucial as it leads up to the 2019 Lok Sabha elections. In its chapter on agriculture titled ‘Agriculture: Doubling Farmer’s...

-India Today While politicians are busy earning brownie points through waving off farmer loans, the farmers in Maharashtra's Pune and Ahmednagar districts have a different story to tell. I had decided to check whether the farmers in Maharashtra are really in favour of the loan waiver after the opposition members were screaming in the legislature almost every day, during the budget session which began on March 9 and concluded on April 17....

-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...